Top-News

Callitas Health News

Keine aktuellen Kursdaten verfügbar
WKN: A2GSU1
ISIN: CA13125C1068
US-Symbol: MPHMF
Typ: Aktie

Callitas Health News

12.06.19 - ACCESSWIRE
Callitas Provides Third Default Status Report
CINCINNATI, OH / ACCESSWIRE / June 12, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its third bi-weekly Default ...
30.05.19 - ACCESSWIRE
Callitas Provides Second Default Status Report
CINCINNATI, OH / ACCESSWIRE / May 30, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) provides its second bi-weekly Default ...
23.05.19 - ACCESSWIRE
Callitas Health, Inc. Announces Closing of Private Placements
NOT FOR ISSUANCE IN THE UNITED STATES
15.05.19 - ACCESSWIRE
Callitas Provides Status Update
CINCINNATI, OH / ACCESSWIRE / May 15, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) announces that further to its news ...
01.05.19 - ACCESSWIRE
Callitas Health Announces Late Filing of Annual Financial Disclosure
CINCINNATI, OH / ACCESSWIRE / May 1, 2019 / Callitas Health Inc. ("Callitas" or the "Company") (CSE: LILY, OTCQB: MPHMF, FWB: T3F3) today announced that the filing of its ...
25.04.19 - ACCESSWIRE
Callitas Health Announces Notice of Allowance for a Biphasic Oral Cannabinoid Patent by U.S. Patent Office, Next Evolution of Cannabis Delivery
CINCINNATI, OH / ACCESSWIRE / April 25, 2019 / Callitas Health Inc. , (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the "Company" or "Callitas") a clinical-​stage pharmaceutical ...
22.04.19 - ACCESSWIRE
Callitas Health Signs Letter of Intent with Simply Wholeistic, LLC to Supply Cannastrip Technology and Dietary Supplements Nationwide
CINCINNATI, OH / ACCESSWIRE / April 22, 2019 / Callitas Health Inc. , (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the ''Company''or ''Callitas'') announced today that it has signed a ...
12.03.19 - ACCESSWIRE
Callitas Health Announces the Promotion of Joshua Maurice to Vice President of Sales and Business Development
CINCINNATI, OH / ACCESSWIRE / March 12, 2019 / Callitas Health Inc. , (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the "Company" or "Callitas") a clinical-​stage pharmaceutical ...
22.01.18 - ACCESSWIRE
Callitas Health Accelerates Commercial Licensing and Engages Feyeur & Trogue, a Specialty Healthcare Consulting Firm
Callitas Health Accelerates Commercial Licensing and Engages Feyeur & Trogue, a Specialty Healthcare Consulting Firm
08.01.18 - PR Newswire
Callitas Health Engages Dr. Laura Berman, World-renowned Sex Educator, Researcher & Therapist As Chief Health Advisor
Callitas Health Engages Dr. Laura Berman, World-​renowned Sex Educator, Researcher & Therapist As Chief Health Advisor PR Newswire
04.01.18 - ACCESSWIRE
Callitas Health Engages Dr. Laura Berman, World-Renowned Sex Educator, Researcher and Therapist as Chief Health Advisor
Callitas Health Engages Dr. Laura Berman, World-​Renowned Sex Educator, Researcher and Therapist as Chief Health Advisor
03.01.18 - ACCESSWIRE
Callitas Announces New Interim CEO and Refiling of Quarter 2 Interim Financial Statements
Callitas Announces New Interim CEO and Refiling of Quarter 2 Interim Financial Statements
16.11.17 - ACCESSWIRE
Callitas Health Announces Patent Application for CannaMint Strips
Callitas Health Announces Patent Application for CannaMint Strips
25.10.17 - ACCESSWIRE
Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team
Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team
19.07.17 - sharedeals.de
Schrottalarm: Aeterna Zentaris und M Pharmaceutical
Aeterna Zentaris (WKN: A1439Z) knallt heute unter hohem Umsatz zeitweise über 90% in die Höhe. Das Unternehmen meldete gestern nach­börslich einen PDUFA-​Termin für sein ...
18.07.17 - IRW-Press
M Pharmaceutical Inc. plant Einreichung einer Anfrage samt Unterlagen für ein PIND-Meeting für Extrinsa™ bei der US-amerikanischen FDA
M Pharmaceutical Inc. plant Einreichung einer Anfrage samt Unterlagen für ein PIND-​Meeting für Extrinsa bei der US-​amerikanischen FDA CINCINNATI, OH, USA (18. Juli 2017) - M ...
13.07.17 - IRW-Press
M Pharmaceutical Inc. informiert die Aktionäre in einem strategischen Bericht über Neuzugänge und Produktentwicklung
M PHARMACEUTICAL INC. informiert die Aktionäre in einem strategischen Bericht über Neuzugänge und Produktentwicklung CINCINNATI, OH, USA (13. Juli 2017) - M ...
11.07.17 - IRW-Press
Blockbuster-Verkaufsstart in Kürze. Neue 700% Biotech-Aktienchance. Der beste Biotech Hotstock M Pharmaceutical Inc. (WKN A14RWC). Besser als Paion und Evotec. - AC Research
Blockbuster-​Verkaufsstart in Kürze. Neue 700% Biotech-​Aktienchance. Der beste Biotech Hotstock M Pharmaceutical Inc. (WKN A14RWC). Besser als Paion und Evotec. 11.07.17 ...
11.07.17 - IRW-Press
M Pharmaceutical Inc. informiert über Neuigkeiten in Bezug auf das von der FDA zugelassene rezeptfreie Produkt ToConceive
M Pharmaceutical Inc. informiert über Neuigkeiten in Bezug auf das von der FDA zugelassene rezeptfreie Produkt ToConceive CINCINNATI, OH, USA (11. Juli 2017) - M ...
07.07.17 - IRW-Press
Dramatische Verbesserungen bei Umsatz und Ergebnis voraus! Der günstigste Biotech Hotstock M Pharmaceutical Inc (WKN A14RWC) Besser als Paion und Evotec! - AC Research
Dramatische Verbesserungen bei Umsatz und Ergebnis voraus! Der günstigste Biotech Hotstock! Besser als Paion und Evotec! 07.07.17 09:26 AC Research Vancouver ...

Newssuche

Videos

newspaper
08:40 Uhr +2,33%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »